June 6, 2016
Evidation Health has raised at least $11.6 million, according to an SEC filing posted last week. The filing lists Raj Ganguly as a director of the company, indicating his venture capital firm, B Capital, participated in this recent round. Ganguly co-founded B Capital with Facebook co-founder Eduardo Saverin and it just raised its newest fund.
A little over a year ago GE Ventures and Stanford...
May 2, 2016
Boston's Brigham and Women’s Hospital, in partnership with Evidation Health, will test Medisafe’s medication adherence app in a randomized control trial of 390 patients taking medication for high blood pressure. Patients will be monitored with an at-home Bluetooth blood pressure cuff.
“I see patients in an acute care setting and there’s a hope that the technology will help people but it’s unclear...
November 19, 2015
Ochsner Health System's O Bar
Evidation Health, a company launched by GE Ventures and Stanford Health, which works with various companies working in healthcare to develop a body of robust clinical evidence for digital health interventions, has announced a partnership with Ochsner Health System.
Ochsner Health, based in New Orleans, was one of the first hospitals to work with Apple's HealthKit...
August 12, 2015
San Mateo, California-based PokitDok, which offers a healthcare price comparison tool and API-based tools for healthcare developers, has raised $34 million, according to Dow Jones' VentureWire. This brings the company's total funding to at least $37 million.
PokitDok was founded by Lisa Maki and Ted Tanner in 2011. The company first offered a mobile app and online service that let users locate...
June 24, 2015
Participants in MIT's 2014 Hackathon with MGH and Samsung.
MIT's Hacking Medicine program, which has organized medical hackathons since 2011, has launched a new spin-off: the Hacking Medicine Institute, a 501c3 nonprofit with a slightly different mission. The new organization will assess whether digital health products and services really work and, if they do, help them to prove their efficacy...